Chemical inhibitors of PHF14 can achieve functional inhibition through various mechanisms by targeting different aspects of the intracellular signaling pathways that PHF14 is known to be involved in. Wortmannin and LY294002 are chemicals that inhibit phosphoinositide 3-kinases (PI3K), a fundamental component upstream of the AKT signaling pathway. By inhibiting PI3K, these chemicals prevent the phosphorylation and activation of AKT, a kinase that is essential for many cellular processes. Since PHF14 is implicated in AKT signaling pathways, its functional activity is dependent on the proper function of AKT. Therefore, inhibition of PI3K results in the reduction of PHF14 activity as the downstream signaling is compromised. Similarly, Triciribine and Perifosine directly inhibit AKT phosphorylation and activation, which leads to a reduction in the signaling pathways involving PHF14, effectively inhibiting its function within the cell. MK-2206, another chemical in this list, is an allosteric inhibitor of AKT which also reduces AKT-mediated signaling processes, thus inhibiting PHF14 activity.
Rapamycin, Palomid 529, and Torin 1 target the mammalian target of rapamycin (mTOR) complex, which is an upstream regulator of protein synthesis, cell growth, and metabolism, where PHF14 is also known to play a role. By binding to mTOR and inhibiting its function, these chemicals indirectly lead to a decrease in PHF14 activity. Spautin-1 promotes the ubiquitin-mediated degradation of PI3K, thus leading to reduced AKT pathway signaling and subsequent decrease in PHF14 activity. GSK690693 and AZD5363 directly inhibit AKT, which is related to the pathways of PHF14, leading to an overall decrease in the functional activity of PHF14. Miltefosine inhibits AKT signaling as well, affecting the pathways where PHF14 is active and thereby inhibiting PHF14's function. Through these diverse yet specific actions, the chemicals collectively contribute to the functional inhibition of PHF14 by targeting the key signaling pathways that are essential for PHF14's role in the cell.
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Inhibits PI3K, which is upstream of AKT signaling pathway. PHF14 is implicated in this pathway and inhibition of PI3K would prevent PHF14 activation. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
Another PI3K inhibitor, leading to reduced AKT pathway activity. As PHF14 is involved in this pathway, inhibition of PI3K would inhibit PHF14 function. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Binds to mTOR complex, an upstream regulator of protein synthesis and cell growth, potentially decreasing the functional activity of PHF14 in these processes. | ||||||
Triciribine | 35943-35-2 | sc-200661 sc-200661A | 1 mg 5 mg | $104.00 $141.00 | 14 | |
Specifically inhibits AKT phosphorylation and activation, which would decrease PHF14's functional activity in its associated signaling pathways. | ||||||
Spautin-1 | 1262888-28-7 | sc-507306 | 10 mg | $168.00 | ||
Induces degradation of PI3K, leading to reduced AKT pathway signaling and downstream inhibition of PHF14 activity. | ||||||
MK-2206 dihydrochloride | 1032350-13-2 | sc-364537 sc-364537A | 5 mg 10 mg | $182.00 $332.00 | 67 | |
Allosteric inhibitor of AKT, leading to a decrease in AKT-mediated signaling processes in which PHF14 is involved, resulting in inhibition of PHF14. | ||||||
Perifosine | 157716-52-4 | sc-364571 sc-364571A | 5 mg 10 mg | $188.00 $327.00 | 1 | |
Inhibits AKT phosphorylation and activation, thereby inhibiting the signaling pathways that involve PHF14. | ||||||
GSK 690693 | 937174-76-0 | sc-363280 sc-363280A | 10 mg 50 mg | $255.00 $1071.00 | 4 | |
Inhibits AKT and its downstream signaling, which would include pathways involving PHF14, leading to inhibition of PHF14 activity. | ||||||
Miltefosine | 58066-85-6 | sc-203135 | 50 mg | $81.00 | 8 | |
Inhibits AKT signaling, affecting the pathways where PHF14 is active, thereby inhibiting PHF14's function. | ||||||
Torin 1 | 1222998-36-8 | sc-396760 | 10 mg | $245.00 | 7 | |
Targets mTOR, a central player in cell growth and metabolism, which is connected to pathways involving PHF14, inhibiting its function. | ||||||